Network Pharmacology, Molecular Docking, and Molecular Dynamic-Based Investigation on the Mechanism of Compound Chrysanthemum in the Treatment of Asthenopia

Table 2

Binding energy of active compounds and hub targets.

Target	Compound	Binding energy (kcal/Mol)
PRKACA	Obtusin	-8.8
PRKCA	Ethyl linolenate	-4.7
	Glycitein	-7.2
	Mandenol	-4.6
	Rhein	-8.1
	Truflex OBP	-6.0
	Wedelolactone	-7.3
PRKCB	Atropine	-6.4
	Glycitein	-8.3
	Lucidusculine	-7.4
	Rhein	-9.0
	Wedelolactone	-8.2